Private Advisor Group, LLC Amgen Inc Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Private Advisor Group, LLC holds 58,270 shares of AMGN stock, worth $18.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

58,270

Previous 60,383 3.5%

Holding current value

$18.6 Million

Previous $18.9 Million 0.48%

% of portfolio

0.12%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $653,719 - $712,883	-2,113 Reduced 3.5%	58,270 $18.8 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $2.35 Million - $2.86 Million	8,954 Added 17.41%	60,383 $18.9 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $486,654 - $587,453	1,810 Added 3.65%	51,429 $14.6 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $19,944 - $22,499	78 Added 0.16%	49,619 $14.3 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $207,498 - $257,615	-949 Reduced 1.88%	49,541 $13.3 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $953,072 - $1.13 Million	4,448 Added 9.66%	50,490 $11.2 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $195,082 - $237,772	-864 Reduced 1.84%	46,042 $11.1 Million
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $847,181 - $1.08 Million	-3,699 Reduced 7.31%	46,906 $0
Q3 2022 Oct 14, 2022	SELL	$224.46 - $253.15 $3.1 Million - $3.5 Million	-13,808 Reduced 21.44%	50,605 $11.4 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $2.13 Million - $2.37 Million	9,239 Added 16.75%	64,413 $15.7 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $424,287 - $469,372	1,935 Added 3.63%	55,174 $13.3 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $4.75 Million - $5.43 Million	-23,864 Reduced 30.95%	53,239 $12 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $6.07 Million - $7.11 Million	28,608 Added 58.99%	77,103 $16.4 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $95,067 - $105,469	-407 Reduced 0.83%	48,495 $11.8 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $616,022 - $717,873	2,776 Added 6.02%	48,902 $12.2 Million
Q4 2020 Apr 01, 2021	BUY	$216.38 - $257.67 $723,141 - $861,133	3,342 Added 7.81%	46,126 $10.6 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $174,344 - $193,885	743 Added 1.77%	42,784 $10.7 Million
Q2 2020 Aug 17, 2020	BUY	$197.81 - $242.74 $140,445 - $172,345	710 Added 1.72%	42,041 $9.92 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $153,810 - $203,994	844 Added 2.08%	41,331 $8.38 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $978,972 - $1.26 Million	-5,174 Reduced 11.33%	40,487 $9.76 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $1.25 Million - $1.5 Million	7,173 Added 18.64%	45,661 $8.94 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $249,049 - $291,942	1,494 Added 4.04%	38,488 $7.09 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $603,201 - $679,939	-3,335 Reduced 8.27%	36,994 $7.03 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $424,948 - $496,051	-2,382 Reduced 5.58%	40,329 $7.85 Million
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $2.8 Million - $3.16 Million	-15,130 Reduced 26.16%	42,711 $8.85 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $5.86 Million - $6.58 Million	35,289 Added 156.48%	57,841 $10.7 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $851,724 - $995,346	-5,027 Reduced 18.23%	22,552 $3.85 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $2.54 Million - $2.84 Million	-15,063 Reduced 35.32%	27,579 $4.96 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $515,420 - $588,471	-3,081 Reduced 6.74%	42,642 $7.91 Million
Q2 2017 Aug 10, 2017	BUY	N/A	45,723	45,723 $7.87 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Amgen Inc Transaction History